ZIC
BMY.RT

ZWJ Investment Counsel’s Bristol-Myers Squibb Company Contingent Value Rights BMY.RT Stock Holding History

ZWJ Investment Counsel’s Portfolio BMY.RT Stock Details BMY.RT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-181,864
Closed -$126K – 175
2020
Q4 		$126K Sell
181,864
-3,385
-2% -$7.21K 0.01% 161
2020
Q3 		$417K Sell
185,249
-5,980
-3% -$17.1K 0.03% 115
2020
Q2 		$685K Buy
191,229
+760
+0.4% +$2.74K 0.06% 96
2020
Q1 		$724K Sell
190,469
-1,950
-1% -$6.42K 0.06% 116
2019
Q4 		$579K Buy
+192,419
New +$500K 0.04% 140

Other funds holding BMY.RT

JCI
Jet Capital Investors New York $51M AUM 48.01% 1-Year Est. Return
Tudor Investment Corp
Tudor Investment Corp Stamford, Connecticut $53.9B AUM 29.12% 1-Year Est. Return
BC
Brookfield Corp Toronto, Ontario, Canada $74.2B AUM 0.68% 1-Year Est. Return
TNB
Thomasville National Bank Thomasville, Georgia $1.82B AUM
WAM
Westport Asset Management Southport, Connecticut $226M AUM 16.76% 1-Year Est. Return
IAIM
International Assets Investment Management Orlando, Florida $1.67B AUM 28.26% 1-Year Est. Return

ZWJ Investment Counsel's BMY.RT Position: Q1 2021 in Review

ZWJ Investment Counsel sold out of Bristol-Myers Squibb Company Contingent Value Rights (BMY.RT) in Q1 2021, closing a stake of 181,864 shares — an estimated $126K sold.

ZWJ Investment Counsel first reported a position in BMY.RT in Q4 2019 and held it in 5 quarters. The position peaked at $724K in Q1 2020. 12 funds tracked by Wall St. Rank hold BMY.RT as of Q1 2021.

  • ZWJ Investment Counsel reported no remaining Bristol-Myers Squibb Company Contingent Value Rights position as of Q1 2021 after selling out during the quarter.
  • ZWJ Investment Counsel sold 181,864 Bristol-Myers Squibb Company Contingent Value Rights shares in Q1 2021, an estimated $126K.
  • ZWJ Investment Counsel first reported a position in Bristol-Myers Squibb Company Contingent Value Rights in Q4 2019 and held it in 5 quarters.
  • ZWJ Investment Counsel's Bristol-Myers Squibb Company Contingent Value Rights position peaked at $724K in Q1 2020.
  • 12 funds tracked by Wall St. Rank held Bristol-Myers Squibb Company Contingent Value Rights as of Q1 2021.

Based on ZWJ Investment Counsel's 13F filing for Q1 2021, filed 6 May 2021.